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Blood pressure (BP) ﬂuctuations after long-term levodopa therapy are rarely reported. Patients with Par-
kinson's disease (PD) often have dysautonomia, and neuropsychiatric and sleep disorders, which inﬂuence
BP. It is difﬁcult to control BPwhen hypertension coexists with these complications.We present the case of
a 78-year-old manwith PD who had hypotensive shock and extreme ﬂuctuations of BP. Fluctuations in BP
with the use of levodopa are more signiﬁcant in patients with motor symptom ﬂuctuations, autonomic
nervous system disorders, primary hypertension, advanced stage of PD, and anxiety or sleep disorders. We
controlled BP ﬂuctuations by dividing the total daily levodopa and benserazide (Madopar) dose into
smaller doses given more often, adding a sedative, and carrying out some simple nonmedical treatments
for postprandial and orthostatic hypotension. At the same time, “dyskinesia” and “wearing-off” were also
improved. BP ﬂuctuations have a considerable inﬂuence on patients' quality of life and can even be life-
threatening. The mechanism is complex, therefore a correct analysis of the underlying causes is needed
to carry out comprehensivemanagement. Adjustment of levodopa administration can not only stabilize BP
well, but also can control PD motor complications.
Copyright © 2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Parkinson's disease (PD), which occurs mainly in older people, is
characterized by movement disorders such as tremor, rigidity,
hypokinesia, abnormal gait, and abnormal posture. Levodopa,
which is converted to dopamine in the body, can ameliorate all the
major clinical features of PD. After long-term levodopa therapy,
patients experience nonmotor symptom ﬂuctuations such as fa-
tigue, anxiety, depression, and pain, as well as motor ﬂuctuations1,
but blood pressure (BP) ﬂuctuations are rarely reported. Most PD
patients have dysautonomia, neuropsychiatric disorders, and sleep
disorders, which inﬂuence the stability of BP, making it difﬁcult to
control BP when hypertension also coexists with these complica-
tions. It is clinically important to evaluate BP ﬂuctuations and carry
out a reasonable management strategy.have no conﬂicts of interest.
ent of Neurology, Geriatric
The Chinese People's Libera-
ct, Beijing 100142, China.
tric Emergency & Critical Care MeWe present the case of a 78-year-old man with PD who had
hypotensive shock and extreme ﬂuctuations of BP. This case illus-
trates the value of a correct analysis and comprehensive manage-
ment (especially the hypotensive effect of levodopa and adjustment
of levodopa administration) of BP ﬂuctuations in a PD patient.
2. Case report
A 78-year-old man had been diagnosed with PD 12 years pre-
viously and had been taking levodopa and benserazide (Madopar)
for 11 years. Dyskinesia symptoms associatedwith levodopa, that is,
head shaking or head and neck twisting to the left, occurred 2 years
earlier. Levodopa “wearing-off”, that is, limb stiffness and asthmatic
symptoms, occurred 1 year earlier. The patient had been dependent
for 6 years and, especially this year, had difﬁculty moving without
support from another person. As a result of dysphagia several
months previously, the patient began receiving nasogastric feeding.
Before he was hospitalized, his daily oral levodopa dosage was
250 mg four times a day. The patient had pramipexole added to his
drug regimen, but had to stop taking pramipexole due to drowsi-
ness and hallucination. Besides having PD, the patient was diag-
nosed as having primary hypertension 40 years earlier. To treatdicine. Published by Elsevier Taiwan LLC. All rights reserved.
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5 mg/day and candesartan 8 mg/day.
The patient's hospitalization resulted from the sudden loss of
consciousness when going to the toilet about 20 days earlier. His BP
was 80/44 mmHg. He was given continuous intravenous dopamine
for 3 days and prescribed absolute bed rest tomaintain sufﬁcient BP
while in a community hospital. Although shock did not occur again,
his BP ﬂuctuated considerably. In particular, his BP began to
decrease signiﬁcantly after he was administered 250 mg of levo-
dopa. Levodopa had been stopped or postponed for some time,
which exacerbated his PD motor symptoms. Therefore, the patient
was sent to our hospital for further treatment.
The patient's Hoehn and Yahr stage was 5.0, and 24-hour BP
monitoring with the PM-7000 Patient Monitor (Mindray Medical
International Limited, shenzhen, China.) showed that the mean
systolic blood pressure (SBP) was 144 ± 34 (range 86e198) mmHg.
However, daytime BP ﬂuctuated sharply. The SBP decreased by anFig. 1. Systolic blood pressure (SBP) ﬂuctuations and their relationship to the time of levodop
axis is time and the Y axis is SBP level. The triangles indicate points of SBP monitoring and
ﬂuctuations with 250 mg levodopa four times per day; (B) SBP ﬂuctuations with 125 mg le
usually decreased 30 minutes after levodopa supplementation and reached its highest point
(mean 79 mmHg, 37 mmHg, 17 mmHg for A, B, C, respectively). “Dyskinesia” also appeared
lowest SBP. However, “wearing-off” appeared 30 minutes before the next administration a
hours in (A) and for 0.5 hours in (B), but disappeared in (C). The “wearing-off” that occurraverage of 79 mmHg after he received 250 mg of levodopa, and
subsequently began to increase until he received his next dose. At
the same time, “dyskinesia” appeared from 30 minutes to 2 hours
after he received levodopa and became most signiﬁcant at the time
of lowest SBP. However, “wearing-off” appeared 30 minutes before
the next administration of levodopa and becamemost signiﬁcant at
the time of the highest SBP (Fig. 1). By contrast, nocturnal and early
morning BP remained at a high level, and the mean SBP was
165 ± 25 (range 118e198) mmHg. In addition, dizziness or syncope
occurred when he sat or stood up.
Initially, we found that daytime BP ﬂuctuations were related to
levodopa, so we tried to change the manner inwhich levodopa was
administered without changing the total dose (1000 mg/day). We
ﬁrst advised the patient to take 125 mg of levodopa every 2 hours.
The SBP decreased by less (average 37 mmHg) after he took levo-
dopa than before adjusting the dose. Dyskinesia was ameliorated
and lasted only about 30 minutes, but “wearing-off” was stilla supplementation and motor complications before and after adjusting levodopa. The X
the squares indicate points of SBP monitoring and levodopa supplementation. (A) SBP
vodopa every 2 hours; (C) SBP ﬂuctuations with 62.5 mg levodopa per hour. The SBP
just before the next administration. SBP decreases became less and less from (A) to (C)
30 minutes after levodopa was taken and became most signiﬁcant at the time of the
nd became most signiﬁcant at the time of the highest SBP. “Dyskinesia” lasted for 1.5
ed in (A) and (B) disappeared in (C).
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then advised the patient to take 62.5 mg levodopa per hour. The
SBP decreased much less (average 17 mmHg) after he took levo-
dopa, and “dyskinesia” and “wearing-off” almost disappeared
(Fig. 1). Next, considering that nocturnal and early morning BP was
much higher, we ordered the patient to take amlodipine and can-
desartan at bedtime, but this change in drug regimen had no effect.
When we further increased the dosage of these two drugs, the
daytime BP decreased unexpectedly with no change in nocturnal
and early morning high BP. Because the patient had insomnia and
anxiety, we added a sedative (estazolam 1 mg) at bedtime, and the
mean nocturnal and early morning SBP decreased to 135 ± 6 (range
122e142) mmHg. Finally, in view of the frequency of autonomic
nervous system disorders in PD, the postprandial and orthostatic
hypotension was tested. Postprandial and orthostatic hypotension
coexisted in this patient, because SBP decreased by 42 mmHg 1
hour after a meal and by 40e50 mmHg from supine to standing
position. We advised the patient to control carbohydrate intake, to
eat less but more often, to avoid quick activity immediately after
each meal, to sleep in the head-up position, to stop eating a low-
sodium diet, and to wear elastic stockings. After the above treat-
ments, SBP decreased by about 20mmHgwith position change, and
no dizziness or syncope occurred while sitting or standing up. The
patient and his familymembers were all providedwritten informed
consent for this report, which was approved by the institutional
review committee of the General Hospital of the Air Force.
3. Discussion
Several factors can affect BP ﬂuctuations. The ﬁrst factor is
levodopa. On the one hand, levodopa reduces supine BP through a
central mechanism, which is more signiﬁcant in patients who have
received long-term levodopa treatment and have motor symptom
ﬂuctuations. This effect is heavily dependent on the levodopa con-
centration. BP is lowest while the symptom is in the “on” phase and
peaks while the symptom is in the “off” phase2,3. On the other hand,
a large dose of levodopa can induce orthostatic and/or postprandial
hypotension through a peripheral mechanism3,4. The second factor
is autonomic nervous system disorderdit is common in PD, and is
the main reason for postprandial and/or orthostatic hypotension5,6.
The third factor is primary hypertension and advanced PD.
High baseline level BP and Hoehn and Yahr stage can enhance the
effects of levodopa and autonomic nervous system disorder on BP
ﬂuctuations3,4,6. Finally, PD is often associated with anxiety and
sleep disorders, which can cause nocturnal and early morning
hypertension7,8.
For PD patients with BP ﬂuctuations, we are inclined to suggest a
comprehensive treatment strategy. Firstly, the mechanism for
levodopa-induced BP ﬂuctuationsmight be similar to that formotor
symptom ﬂuctuations, that is, pulsative dopaminergic stimulation
and dopamine receptor hypersensitization9. To avoid these
effects, we could choose levodopa sustained-release tablets,dopamine receptor agonists, continuous infusions of levodopa or
dopamine agonists by intraduodenal administration, or deep brain
stimulation10,11. However, we could not carry out the above strate-
gies for several reasons, including dysphagia, agonist side effects,
and lack of availability of intraduodenal infusion and deep brain
stimulation, so we changed the manner of levodopa administration
bydividing the total daily dose into smaller doses andmore frequent
drug administration. Secondly, sedative and anxiolytic drugs can
modify nocturnal and early morning hypertension in mood and
sleep disorders7,8. Thirdly, although some drugs (e.g., caffeine,
glycosidase inhibitors, octreotide, vasoactive agents, and plasma
volume expansion agents) can be used to treat postprandial and
orthostatic hypotension, considering these drugs' uncertain effects,
serious side effects, or high costs, as well as baseline primary hy-
pertension, we used some simple nonmedical methods instead5,12.
In conclusion, in older PD patients, BP ﬂuctuations will inﬂuence
the patient's quality of life considerably, and can even be life-
threatening. The mechanism of the BP ﬂuctuations is complex, so
the reasons for the ﬂuctuations (especially the hypotensive effect of
levodopa) should be carefully analyzed and comprehensive man-
agement to control the BP ﬂuctuations should be carried out. If only
the adjustment of antihypertension drugs is considered, this will
not only result in the failure of BP control, but also cause hypo-
tensive shock. The adjustment of levodopa administration can not
only stabilize BP well, but also control PD motor complications.References
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